George Elston | CFO |
Nancy Lurker | President and CEO |
Jay Duker | COO |
Scott Jones | CCO |
Georgi Yordanov | Cowen |
Yatin Suneja | Guggenheim Securities |
Jennifer Kim | Cantor Fitzgerald |
Yale Jen | Laidlaw & Company |
Yi Chen | H.C. Wainwright |
Good morning. My name is Josh and I will be your conference operator today. At this time, I would like to welcome everyone to the EyePoint Pharmaceuticals First Quarter 2022 Financial Results and Recent Corporate Development's Conference Call. There will be a question-and-answer session to follow at the completion of the prepared remarks. Please be advised that this call is being recorded at the company's request.